$9.64
-3.8%DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Chief Executive Officer, President & Director
Compensation
$2,020,463
Executive Vice President of Corporate Development, General Counsel & Secretary
Compensation
$922,637
Interim Chief Financial Officer
Senior Vice President & Chief Human Resources Officer
Senior Vice President & Chief Supply Chain Officer and Head of Sustainability
Compensation
$900,140
Senior Vice President & Chief Technology Officer
Senior Vice President of Global Business Unit Leader
Senior Vice President of Global Quality and Regulatory & Chief Quality Officer
Vice President & Chief Accounting Officer
Vice President of Investor Relations
During the last 12 months, insiders have purchased $1.12M and sold $916K worth of XRAY shares, resulting in $208K of net buying activity.
20.0K
249.07K
0
0.00
+249K
+$249K
55.0K
774.72K
82.2K
915.71K
-141K
-$141K
9.3K
100.00K
0
0.00
+100K
+$100K
0
0.00
0
0.00
+0
+$0
Lucier Gregory T
Director
$894K
Forbes James D
Director
$130K
Varon Leslie F
Director
$100K
Lucier Gregory T
Director
$916K
Moderately bullish with $208K net buying. Insiders show cautious optimism through measured share purchases.
Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
3 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Broad-based insider buying: When multiple insiders independently decide to purchase shares, it often reflects genuine confidence rather than coordinated optics. This pattern deserves attention, especially if buying followed a price decline.
XRAY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 23, 2026 | June 02, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 09, 2025 | May 21, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 10, 2024 | May 22, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 14, 2023 | April 14, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 13, 2022 | May 25, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 16, 2021 | May 26, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 07, 2020 | May 20, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 12, 2019 | May 22, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 09, 2018 | May 23, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 13, 2017 | May 24, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.